Browse By

Category Archives: Biotech&Pharma

[Biotech&Pharma] Biotech Stocks Are On Fire — Who's Leading The Profit Pack For 2020?

Finding the best biotech companies to invest in can be tricky as volatility often pockmarks the space. Clinical plans don't always come to fruition and sometimes biotech stocks can suffer at the hands of regulatory decisions from the Food and Drug Administration. X {“@context”:””,”@type”:”VideoObject”,”name”:”Investing Strategies:

[Biotech&Pharma] CytoDyn Signs Letter of Intent for the Joint Development and Licensing of Leronlimab in China with Longen China Group

VANCOUVER, Washington, Feb. 12, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that the Company signed a nonbinding letter of intent

[Biotech&Pharma] These 5 Pharma Stocks Are Leading The Group Heading Into 2020

Pharmaceutical stocks posted a single-digit gain in 2019, far below the bullish 28% pop for their biotech counterparts. Still, there are standouts in the pharma industry group. The best pharmaceutical stocks to buy have several commonalities, including strong Composite Ratings and Relative Strength Ratings. X {“@context”:””,”@type”:”VideoObject”,”name”:”How

[Biotech&Pharma] Leading Biotech Stock Crashes After Promising Drug Fails Late-Stage Test

Incyte stock crashed late Thursday after the biotech company's treatment for graft vs. host disease failed in a late-stage study. X {“@context”:””,”@type”:”VideoObject”,”name”:”How To Buy Stocks: Market Timing”,”description”:”Before you buy any stock, make sure you understand the current market conditions. History shows that the vast majority

[Biotech&Pharma] Aldevron Adds DasherGFP® mRNA to its Product Portfolio

Fargo, N.D., Feb. 12, 2020 (GLOBE NEWSWIRE) — Aldevron, a global leader in the custom development and manufacture of plasmid DNA, proteins, mRNA and antibodies for the biotech industry, announced today the addition of DasherGFP (green fluorescent protein) mRNA to its off-the-shelf product portfolio.  The DasherGFP mRNA encodes an IP-free, fluorescent protein engineered by ATUM, a collaborating